Eltoukhy Helmy
Co-Chief Executive Officer
Eltoukhy Helmy has filed 10 SEC Form 4 filings (40 transaction rows) across 1 company, with disclosures dating back to 2025. 10 of those filings fall inside the rolling window. Most recent filing: Aug 27, 2026.
On the most recent filing, Eltoukhy Helmy is listed as Co-Chief Executive Officer at Guardant Health, Inc. Inside the rolling window, Eltoukhy Helmy reported no open-market purchases and 3 open-market sales totaling $39.9M in GH. The largest disclosed transaction in the window is a sale of 300,000 GH shares on Sep 9, 2025, worth $17.8M.
Companies traded
Other insiders at GH
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$39.9M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Eltoukhy Helmy made?
Eltoukhy Helmy has filed 10 SEC Form 4 filings (40 transaction rows) across 1 company since 2025.
Which companies does Eltoukhy Helmy trade?
Eltoukhy Helmy has filed SEC Form 4 disclosures for 1 company, including GH.
When was Eltoukhy Helmy's most recent SEC Form 4 filing?
Eltoukhy Helmy's most recent SEC Form 4 filing on Tracefour is dated Aug 27, 2026.
What is Eltoukhy Helmy's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Eltoukhy Helmy is listed as Co-Chief Executive Officer.
What is Eltoukhy Helmy's total buy and sell value in the current window?
Inside the rolling retention window, Eltoukhy Helmy bought $0 and sold $39.9M based on SEC Form 4 filings.
What was Eltoukhy Helmy's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 300,000 GH shares on 2025-09-09, worth $17.8M, per SEC Form 4 filings.